MY8100025A - Vinca alkaloid derivatives - Google Patents

Vinca alkaloid derivatives

Info

Publication number
MY8100025A
MY8100025A MY25/81A MY8100025A MY8100025A MY 8100025 A MY8100025 A MY 8100025A MY 25/81 A MY25/81 A MY 25/81A MY 8100025 A MY8100025 A MY 8100025A MY 8100025 A MY8100025 A MY 8100025A
Authority
MY
Malaysia
Prior art keywords
vinca alkaloid
alkaloid derivatives
derivatives
vinca
alkaloid
Prior art date
Application number
MY25/81A
Inventor
George Joseph Cullinan
Kdert Gerzon
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MY8100025A publication Critical patent/MY8100025A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
MY25/81A 1973-04-02 1981-12-30 Vinca alkaloid derivatives MY8100025A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34727573A 1973-04-02 1973-04-02

Publications (1)

Publication Number Publication Date
MY8100025A true MY8100025A (en) 1981-12-31

Family

ID=23363051

Family Applications (1)

Application Number Title Priority Date Filing Date
MY25/81A MY8100025A (en) 1973-04-02 1981-12-30 Vinca alkaloid derivatives

Country Status (28)

Country Link
JP (2) JPS5919117B2 (en)
AR (2) AR204004A1 (en)
AT (1) AT340605B (en)
BE (1) BE813168A (en)
BG (3) BG21612A3 (en)
CA (1) CA1042428A (en)
CH (1) CH603669A5 (en)
CS (1) CS185223B2 (en)
CY (1) CY1044A (en)
DD (1) DD113538A5 (en)
DE (1) DE2415980A1 (en)
DK (1) DK141511B (en)
ES (2) ES424882A1 (en)
FR (1) FR2223044B1 (en)
GB (1) GB1463575A (en)
HK (1) HK20180A (en)
HU (1) HU171572B (en)
IE (1) IE39071B1 (en)
IL (1) IL44415A (en)
KE (1) KE3028A (en)
MY (1) MY8100025A (en)
NL (1) NL181079C (en)
PH (1) PH13623A (en)
RO (2) RO77533A (en)
SE (1) SE416206B (en)
SU (4) SU731900A3 (en)
YU (3) YU39719B (en)
ZA (1) ZA741674B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48685A (en) * 1975-01-09 1980-03-31 Lilly Co Eli Amides of vincadioline and vinblastine
GR69783B (en) * 1976-09-08 1982-07-07 Lilly Co Eli
USRE30560E (en) * 1976-12-06 1981-03-31 Eli Lilly And Company Oxazolidinedione derivatives of Vinca alkaloids
US4096148A (en) * 1976-12-06 1978-06-20 Eli Lilly And Company Oxazolidinedione derivatives of Vinca alkaloids
USRE30561E (en) 1976-12-06 1981-03-31 Eli Lilly And Company Vinca alkaloid intermediates
US4203898A (en) 1977-08-29 1980-05-20 Eli Lilly And Company Amide derivatives of VLB, leurosidine, leurocristine and related dimeric alkaloids
US4199504A (en) * 1978-05-15 1980-04-22 Eli Lilly And Company Bridged cathranthus alkaloid dimers
US4357334A (en) 1980-03-20 1982-11-02 Eli Lilly And Company Use of VLB 3-(2-chloroethyl) carboxamide in treating neoplasms
OA06421A (en) * 1980-06-10 1981-09-30 Omnium Chimique Sa Process for the preparation of N- (vinblastinoyl-23) derivatives of amino acids and peptides.
LU83822A1 (en) 1981-12-08 1983-09-01 Omnichem Sa N- (VINBLASTINOYL-23) DERIVATIVES OF AMINO ACIDS, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
FR2623504B1 (en) * 1987-11-25 1990-03-09 Adir NOVEL N- (VINBLASTINOYL-23) DERIVATIVES OF 1-AMINO METHYLPHOSPHONIC ACID, PROCESSES FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
HUT76925A (en) * 1995-04-04 1998-01-28 MTA Enzimológiai Intézet Bis-indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them
US5948750A (en) * 1996-10-30 1999-09-07 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US6326402B1 (en) 1998-08-12 2001-12-04 Octamer, Inc. Methods for treating viral infections using a compound capable of inhibiting microtubules
CA2594474C (en) 2005-01-21 2016-03-29 Astex Therapeutics Limited Pharmaceutical compounds
CN101242822B (en) 2005-07-18 2011-08-24 彼帕科学公司 Medicine of ovarian cancer
JP2010502730A (en) 2006-09-05 2010-01-28 バイパー サイエンシズ，インコーポレイティド Cancer treatment
CN101534836B (en) 2006-09-05 2011-09-28 彼帕科学公司 Use of PARP inhibition in preparing medicine for obesity
EP2073807A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
WO2009064738A2 (en) 2007-11-12 2009-05-22 Bipar Sciences, Inc. Treatment of breast cancer with a parp inhibitor alone or in combination with anti-tumor agents
EP2987794B1 (en) * 2013-04-19 2018-05-30 Jinan University Vinblastine derivatives, preparation method therefor and application thereof
CN113456797B (en) * 2021-06-18 2024-03-08 暨南大学 Application of vinblastine derivatives in preparation of medicines for treating osteosarcoma and/or soft tissue sarcoma

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097137A (en) * 1960-05-19 1963-07-09 Canadian Patents Dev Vincaleukoblastine

Also Published As

Publication number Publication date
SU784783A3 (en) 1980-11-30
CY1044A (en) 1980-08-01
JPS59193895A (en) 1984-11-02
FR2223044A1 (en) 1974-10-25
YU39719B (en) 1985-04-30
RO77533A (en) 1982-02-01
SU731900A3 (en) 1980-04-30
AR203882A1 (en) 1975-10-31
DE2415980A1 (en) 1974-10-10
NL7404423A (en) 1974-10-04
JPS49128000A (en) 1974-12-07
BG21235A3 (en) 1976-03-20
SU652896A3 (en) 1979-03-15
ATA267974A (en) 1977-04-15
DK141511B (en) 1980-04-08
AT340605B (en) 1977-12-27
YU39875B (en) 1985-04-30
NL181079C (en) 1987-06-16
BE813168A (en) 1974-10-02
RO73524A (en) 1984-10-31
IE39071B1 (en) 1978-08-02
PH13623A (en) 1980-08-07
FR2223044B1 (en) 1978-06-30
YU113880A (en) 1982-05-31
KE3028A (en) 1980-03-28
ES446571A1 (en) 1977-06-16
ES424882A1 (en) 1976-12-16
HK20180A (en) 1980-04-25
AU6671974A (en) 1975-09-18
YU81774A (en) 1982-05-31
AR204004A1 (en) 1975-11-12
CA1042428A (en) 1978-11-14
GB1463575A (en) 1977-02-02
CS185223B2 (en) 1978-09-15
NL181079B (en) 1987-01-16
ZA741674B (en) 1975-10-29
DE2415980C2 (en) 1989-11-09
IL44415A0 (en) 1974-06-30
IE39071L (en) 1974-10-02
DK141511C (en) 1980-09-29
YU113980A (en) 1982-05-31
RO73524B (en) 1984-11-30
CH603669A5 (en) 1978-08-31
HU171572B (en) 1978-02-28
SU623522A3 (en) 1978-09-05
SE416206B (en) 1980-12-08
BG21612A3 (en) 1976-07-20
JPS6033837B2 (en) 1985-08-05
YU39876B (en) 1985-04-30
DD113538A5 (en) 1975-06-12
BG22831A3 (en) 1977-04-20
IL44415A (en) 1978-08-31
JPS5919117B2 (en) 1984-05-02

Similar Documents

Publication Publication Date Title
MY8100256A (en) Cephalosporin derivatives
KE3028A (en) Vinca alkaloid derivatives
ZA743760B (en) Xanthine derivatives
HK13379A (en) Pyrazino-isoquinoline derivatives
PH10309A (en) Penicillin derivatives
IL45505A0 (en) Cephalosporin derivatives
HK53980A (en) Vincamine derivatives
GB1483352A (en) Phenyl-alkenol and-alkanol derivatives
IL43704A0 (en) Lactamimide derivatives
IL45307A0 (en) Cephalosporin derivatives
ZA745496B (en) Cephalosporin derivatives
PH12303A (en) Thienotriazolodiazepine derivatives
MY8100185A (en) Dihydroergopeptine derivatives
HK181A (en) Benzylpyrimidine derivatives
PH11117A (en) Cephalosporin derivatives
GB1483621A (en) Rifamycin derivatives
ZA741498B (en) Imidazo heterocyclic derivatives
IL44119A0 (en) Ergoline derivatives
IL44831A0 (en) Pyrazinoisoquinoline derivatives
AU7333774A (en) Arylchalcogeno-hydrocarbon derivatives
AU7333674A (en) Arylchalcogeno-hydrocarbon derivatives
GB1408550A (en) Gitoxigenin-digitoxoside derivatives
IL41634A0 (en) Penicillin derivatives
ZA747137B (en) Penicillin derivatives
IE39707L (en) Dibenzothiepin and -oxepin derivatives